.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Molecular engineering has enabled the creation of advanced NIR-II phototheranostic agents for precise cancer management. Researchers recently developed a novel ionic small-molecule agent called 2PyI. By carefully balancing positive charges and hydrophilicity, they achieved an optimal amphiphilic structure. Consequently, this innovation allows for high-resolution imaging and powerful therapeutic effects.
The 2PyI agent provides several critical functions within a single molecule. First, it enables efficient NIR-II emission, which is essential for deep-tissue imaging. Furthermore, it produces reactive oxygen species to destroy malignant cells. It also facilitates photothermal conversion to generate localized heat. Therefore, this synergistic approach enhances the efficacy of both photodynamic and photothermal therapies.
In addition to its therapeutic power, the high-resolution imaging guides clinicians during treatment. Traditional imaging methods often struggle with deep-seated tumors. However, NIR-II light penetrates biological tissues much more effectively than visible light. Because of this, the new agent offers a promising platform for image-guided oncology. Ultimately, such molecular engineering paves the way for more effective and less invasive cancer treatments.
NIR-II imaging uses the second near-infrared window to provide deep tissue penetration and high resolution. This allows doctors to locate tumors more accurately than with conventional imaging.
It combines photodynamic therapy, which uses light to create reactive oxygen species, with photothermal therapy, which generates heat. Together, they provide a more potent effect against cancer cells.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional recommendation. Refer to the latest local and national guidelines for clinical practice.
References
Gong J et al. Molecular engineering of ionic organic phototheranostic agents for NIR-II imaging-guided synergistic phototherapy. Chem Commun (Camb). 2026 Feb 23. doi: 10.1039/d6cc00306k. PMID: 41725580.
Zhang X, et al. Recent advances in near-infrared-II (NIR-II) small molecule fluorophores for cancer theranostics. Journal of Materials Chemistry B. 2025.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Researchers develop 2PyI, an ionic small-molecule agent for high-resolution NIR-II imaging and synergistic photodynamic/photothermal therapy....
5 months ago
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
